Novartis | Creditori Commerciali



Trade Creditors Cambiamento Data
AbbVie 2.94B 2.66B 2024-12
Amgen USD 1.91B 239M 2024-12
AstraZeneca 22.46B 781M 2024-12
Bausch Health Companies USD 667M 88M 2024-09
Biogen USD 424.2M 1.5M 2024-12
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Canopy Growth CAD 25.49M 50.74M 2024-06
Corcept Therapeutics USD 15.38M 3.21M 2024-12
Drreddys Laboratories INR 36.02B 246M 2024-12
Eli Lilly USD 3.23B 342.1M 2024-12
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.34B 960M 2024-12
Glaxosmithkline 13.47B 1.15B 2024-09
Indivior 50M 4M 2024-09
J&J USD 10.31B 1.36B 2024-12
Merck USD 4.08B 493M 2024-12
Novartis USD 4.57B 485M 2024-12
Novartis USD 4.57B 485M 2024-12
Pacira USD 19.13M 234K 2024-12
Perrigo USD 495.2M 36.7M 2024-12
Pfizer USD 5.63B 319M 2024-12
Prestige Brands USD 19.51M 11.67M 2024-12
Roche Holding 4.35B 828M 2024-12
Sanofi 7.43B 105M 2024-06
Sanofi 7.43B 105M 2024-06
Supernus Pharmaceuticals USD 4.59M 1.8M 2024-12
Zoetis USD 433M 29M 2024-12



Novartis Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.